1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy of alpelisib in PI3K-driven langerhans cell histiocytosis
    Meeting Abstract

    Mazor, R. D.; Durham, B. H.; Abdel-Wahab, O. I.; Diamond, E. L.; Yabe, M.; Itchaki, G.; Ben-Sasson, M.; Hershkovitz-Rokah, O.; Shpilberg, O.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Genomic analysis of patients across continental ancestry groups
    Meeting Abstract

    Carrot-Zhang, J.; New, J.; Xie, A.; Frampton, G.
    Cancer Epidemiology Biomarkers and Prevention (2023)

    Fulltext@MSK | Save
  • Polyethnic-1000: A New York-based initiative to advance cancer genomics through recruitment of diverse racial & ethnic populations
    Meeting Abstract

    Balogun, O.; Davis, M.; Mehallow, M.; Robine, N.; Winterkorn, L.; Oschwald, D.; Zody, M.; Aparicio, S.; Maniatis, T.; Varmus, H.; more...
    Cancer Epidemiology Biomarkers and Prevention (2023)

    Fulltext@MSK | Save
  • Metabolic determinants of tumour initiation
    Review

    Brunner, J. S.; Finley, L. W. S.
    Nature Reviews Endocrinology (2023)

    Fulltext@MSK | Save
  • Total lesion glycolysis and the impact of tumor absorbed dose following radioembolization of breast cancer liver metastases
    Meeting Abstract

    Sarkar, D.; Mendoza, H.; Zhao, K.; Bryce, Y.; Deipolyi, A.; Bromberg, J.; Yarmohammadi, H.; Sofocleous, C.; Solomon, S.
    Journal of Vascular and Interventional Radiology (2023)

    Fulltext@MSK | Save
  • STARLITE 2: Phase 2 study of nivolumab plus (177)lutetium-labeled anti–carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients (pts) with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Lee, C. H.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and immunogenomic outcomes of consolidative cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint blockade
    Meeting Abstract

    Reese, S. W.; Jiang, H.; Kuo, F.; Wu, C. Y.; Vuong, L.; Mascareno, E.; Oparanozie, A.; Motzer, R. J.; Voss, M. H.; Reznik, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Correlating HLA variants and the emergence of immune-related adverse events (irAEs) from ipilimumab/nivolumab (I/N) in patients (pts) treated on CheckMate 214
    Meeting Abstract

    Voss, M. H.; Shah, N. J.; Kalvin, H. L.; Lihm, J.; Li, H.; Kotecha, R. R.; Jarchum, I.; Vemula, S. V.; Gupta, S.; Motzer, R. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Characterizing the immune phenotype of FGFR3 mutated upper tract urothelial carcinoma (UTUC) using single-cell (sc)RNA-sequencing (seq)
    Meeting Abstract

    Katims, A. B.; Kuo, F.; Reisz, P.; Tracey, A.; Thomas, J.; Yip, W.; Merghoub, T.; Bochner, B. H.; Pietzak, E. J.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save